The integrated Translational Health Research Institute of Virginia

Turning observations in the laboratory, clinic, and community into interventions that improve Health

About

The integrated Translational Health Research Institute of Virginia (iTHRIV) is a transformational cross-Commonwealth collaboration that leverages the latest advances in data science to accelerate innovation in health-related research and facilitate team science. Partners within iTHRIV include Carilion Clinic, Inova Health System, the University of Virginia, and Virginia Tech, as well as affiliates the Center for Open Science and the UVA Licensing & Ventures Group.

"The best way to find yourself is to lose yourself in the service of others."

Mahatma Gandhi

iTHRIV in the News

The integrated Translational Health Research Institute of Virginia, or iTHRIV, has awarded pilot funding to five medical research projects.

The Integrated Translational Health Institute of Virginia, also known as iTHRIV, developed an online tool collecting information related to COVID-19 from volunteers who live in Virginia, according to a news release from UVA Health.

The integrated Translational Research Institute of Virginia today announced its fourth class of iTHRIV Scholars.

iTHRIV is thrilled to announce that Dr. Tom Hartka's paper examining the accuracy of algorithms in predicting traumatic injury in older adults has been chosen to receive the Best Paper Award from the 2019 Annual Scientific Conference of the AAAM.

Diffusion Pharmaceuticals is currently partnering with the University of Virginia and iTHRIV in a research program to develop its novel small molecule TSC as a treatment for Acute Respiratory Distress Syndrome (ARDS) from COVID-19, specifically targeting the associated multiple organ failure.

Dr. Sana Syed is a pediatric gastroenterologist with UVA Health. She and others began talking about immediate action to fight inequality in their communities and to promote diversity in their professions and schools.

Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests. Researcher Kathleen A. McManus, MD, said increasing enrollment in the plans could help in the effort to end the HIV epidemic.

Contact the integrated Translational Health Research Institute of Virginia

560 Ray C. Hunt Drive PO Box 800751 Charlottesville, VA 22903

(434)924-6208